The global Amino Acid Metabolism Disorder Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Amino Acid Metabolism Disorder Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amino Acid Metabolism Disorder Drug.

Report Scope

The Amino Acid Metabolism Disorder Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amino Acid Metabolism Disorder Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Amino Acid Metabolism Disorder Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Amino Acid Metabolism Disorder Drug Market Report

Report Metric	Details
Report Name	Amino Acid Metabolism Disorder Drug Market
CAGR	5%
Segment by Type	Arginine Folic Acid Vitamin B6 & B12 Thiamine Vitamin D Betaine Carglumic Acid Sapropterin Dihydrochloride Others
Segment by Application	Phenylketonuria Maple Syrup Urine Disease Argininosuccinic Acidemia Citrullinemia Homocystinuria
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Pfizer, AMINO, Merck, Recordati, DSM, Sanofi, Kyowa Hakko Kirin, BioMarin, Swedish Orphan Biovitrum, Shine Star (Hubei) Biological Engineering
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amino Acid Metabolism Disorder Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Amino Acid Metabolism Disorder Drug Market report?

Ans: The main players in the Amino Acid Metabolism Disorder Drug Market are GlaxoSmithKline, Pfizer, AMINO, Merck, Recordati, DSM, Sanofi, Kyowa Hakko Kirin, BioMarin, Swedish Orphan Biovitrum, Shine Star (Hubei) Biological Engineering

What are the Application segmentation covered in the Amino Acid Metabolism Disorder Drug Market report?

Ans: The Applications covered in the Amino Acid Metabolism Disorder Drug Market report are Phenylketonuria, Maple Syrup Urine Disease, Argininosuccinic Acidemia, Citrullinemia, Homocystinuria

What are the Type segmentation covered in the Amino Acid Metabolism Disorder Drug Market report?

Ans: The Types covered in the Amino Acid Metabolism Disorder Drug Market report are Arginine, Folic Acid, Vitamin B6 & B12, Thiamine, Vitamin D, Betaine, Carglumic Acid, Sapropterin Dihydrochloride, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Arginine

1.2.3 Folic Acid

1.2.4 Vitamin B6 & B12

1.2.5 Thiamine

1.2.6 Vitamin D

1.2.7 Betaine

1.2.8 Carglumic Acid

1.2.9 Sapropterin Dihydrochloride

1.2.10 Others

1.3 Market by Application

1.3.1 Global Amino Acid Metabolism Disorder Drug Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Phenylketonuria

1.3.3 Maple Syrup Urine Disease

1.3.4 Argininosuccinic Acidemia

1.3.5 Citrullinemia

1.3.6 Homocystinuria

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Amino Acid Metabolism Disorder Drug Market Perspective (2019-2030)

2.2 Amino Acid Metabolism Disorder Drug Growth Trends by Region

2.2.1 Global Amino Acid Metabolism Disorder Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Amino Acid Metabolism Disorder Drug Historic Market Size by Region (2019-2024)

2.2.3 Amino Acid Metabolism Disorder Drug Forecasted Market Size by Region (2025-2030)

2.3 Amino Acid Metabolism Disorder Drug Market Dynamics

2.3.1 Amino Acid Metabolism Disorder Drug Industry Trends

2.3.2 Amino Acid Metabolism Disorder Drug Market Drivers

2.3.3 Amino Acid Metabolism Disorder Drug Market Challenges

2.3.4 Amino Acid Metabolism Disorder Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Amino Acid Metabolism Disorder Drug Players by Revenue

3.1.1 Global Top Amino Acid Metabolism Disorder Drug Players by Revenue (2019-2024)

3.1.2 Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Players (2019-2024)

3.2 Global Amino Acid Metabolism Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Amino Acid Metabolism Disorder Drug Revenue

3.4 Global Amino Acid Metabolism Disorder Drug Market Concentration Ratio

3.4.1 Global Amino Acid Metabolism Disorder Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Amino Acid Metabolism Disorder Drug Revenue in 2023

3.5 Amino Acid Metabolism Disorder Drug Key Players Head office and Area Served

3.6 Key Players Amino Acid Metabolism Disorder Drug Product Solution and Service

3.7 Date of Enter into Amino Acid Metabolism Disorder Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Amino Acid Metabolism Disorder Drug Breakdown Data by Type

4.1 Global Amino Acid Metabolism Disorder Drug Historic Market Size by Type (2019-2024)

4.2 Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Type (2025-2030)

5 Amino Acid Metabolism Disorder Drug Breakdown Data by Application

5.1 Global Amino Acid Metabolism Disorder Drug Historic Market Size by Application (2019-2024)

5.2 Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Amino Acid Metabolism Disorder Drug Market Size (2019-2030)

6.2 North America Amino Acid Metabolism Disorder Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024)

6.4 North America Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Amino Acid Metabolism Disorder Drug Market Size (2019-2030)

7.2 Europe Amino Acid Metabolism Disorder Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024)

7.4 Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size (2019-2030)

8.2 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2019-2024)

8.4 Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Amino Acid Metabolism Disorder Drug Market Size (2019-2030)

9.2 Latin America Amino Acid Metabolism Disorder Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024)

9.4 Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size (2019-2030)

10.2 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024)

10.4 Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Detail

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Introduction

11.1.4 GlaxoSmithKline Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)

11.1.5 GlaxoSmithKline Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Detail

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Amino Acid Metabolism Disorder Drug Introduction

11.2.4 Pfizer Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)

11.2.5 Pfizer Recent Development

11.3 AMINO

11.3.1 AMINO Company Detail

11.3.2 AMINO Business Overview

11.3.3 AMINO Amino Acid Metabolism Disorder Drug Introduction

11.3.4 AMINO Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)

11.3.5 AMINO Recent Development

11.4 Merck

11.4.1 Merck Company Detail

11.4.2 Merck Business Overview

11.4.3 Merck Amino Acid Metabolism Disorder Drug Introduction

11.4.4 Merck Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)

11.4.5 Merck Recent Development

11.5 Recordati

11.5.1 Recordati Company Detail

11.5.2 Recordati Business Overview

11.5.3 Recordati Amino Acid Metabolism Disorder Drug Introduction

11.5.4 Recordati Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)

11.5.5 Recordati Recent Development

11.6 DSM

11.6.1 DSM Company Detail

11.6.2 DSM Business Overview

11.6.3 DSM Amino Acid Metabolism Disorder Drug Introduction

11.6.4 DSM Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)

11.6.5 DSM Recent Development

11.7 Sanofi

11.7.1 Sanofi Company Detail

11.7.2 Sanofi Business Overview

11.7.3 Sanofi Amino Acid Metabolism Disorder Drug Introduction

11.7.4 Sanofi Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)

11.7.5 Sanofi Recent Development

11.8 Kyowa Hakko Kirin

11.8.1 Kyowa Hakko Kirin Company Detail

11.8.2 Kyowa Hakko Kirin Business Overview

11.8.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Introduction

11.8.4 Kyowa Hakko Kirin Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)

11.8.5 Kyowa Hakko Kirin Recent Development

11.9 BioMarin

11.9.1 BioMarin Company Detail

11.9.2 BioMarin Business Overview

11.9.3 BioMarin Amino Acid Metabolism Disorder Drug Introduction

11.9.4 BioMarin Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)

11.9.5 BioMarin Recent Development

11.10 Swedish Orphan Biovitrum

11.10.1 Swedish Orphan Biovitrum Company Detail

11.10.2 Swedish Orphan Biovitrum Business Overview

11.10.3 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Introduction

11.10.4 Swedish Orphan Biovitrum Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)

11.10.5 Swedish Orphan Biovitrum Recent Development

11.11 Shine Star (Hubei) Biological Engineering

11.11.1 Shine Star (Hubei) Biological Engineering Company Detail

11.11.2 Shine Star (Hubei) Biological Engineering Business Overview

11.11.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Introduction

11.11.4 Shine Star (Hubei) Biological Engineering Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024)

11.11.5 Shine Star (Hubei) Biological Engineering Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Swedish Orphan Biovitrum

Shine Star (Hubei) Biological Engineering

List of Tables

Table 1. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Arginine

Table 3. Key Players of Folic Acid

Table 4. Key Players of Vitamin B6 & B12

Table 5. Key Players of Thiamine

Table 6. Key Players of Vitamin D

Table 7. Key Players of Betaine

Table 8. Key Players of Carglumic Acid

Table 9. Key Players of Sapropterin Dihydrochloride

Table 10. Key Players of Others

Table 11. Global Amino Acid Metabolism Disorder Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 12. Global Amino Acid Metabolism Disorder Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 13. Global Amino Acid Metabolism Disorder Drug Market Size by Region (2019-2024) & (US$ Million)

Table 14. Global Amino Acid Metabolism Disorder Drug Market Share by Region (2019-2024)

Table 15. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 16. Global Amino Acid Metabolism Disorder Drug Market Share by Region (2025-2030)

Table 17. Amino Acid Metabolism Disorder Drug Market Trends

Table 18. Amino Acid Metabolism Disorder Drug Market Drivers

Table 19. Amino Acid Metabolism Disorder Drug Market Challenges

Table 20. Amino Acid Metabolism Disorder Drug Market Restraints

Table 21. Global Amino Acid Metabolism Disorder Drug Revenue by Players (2019-2024) & (US$ Million)

Table 22. Global Amino Acid Metabolism Disorder Drug Market Share by Players (2019-2024)

Table 23. Global Top Amino Acid Metabolism Disorder Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amino Acid Metabolism Disorder Drug as of 2023)

Table 24. Ranking of Global Top Amino Acid Metabolism Disorder Drug Companies by Revenue (US$ Million) in 2023

Table 25. Global 5 Largest Players Market Share by Amino Acid Metabolism Disorder Drug Revenue (CR5 and HHI) & (2019-2024)

Table 26. Key Players Headquarters and Area Served

Table 27. Key Players Amino Acid Metabolism Disorder Drug Product Solution and Service

Table 28. Date of Enter into Amino Acid Metabolism Disorder Drug Market

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Amino Acid Metabolism Disorder Drug Market Size by Type (2019-2024) & (US$ Million)

Table 31. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2019-2024)

Table 32. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 33. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2025-2030)

Table 34. Global Amino Acid Metabolism Disorder Drug Market Size by Application (2019-2024) & (US$ Million)

Table 35. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2019-2024)

Table 36. Global Amino Acid Metabolism Disorder Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 37. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2025-2030)

Table 38. North America Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024) & (US$ Million)

Table 43. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030) & (US$ Million)

Table 44. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 45. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2019-2024) & (US$ Million)

Table 46. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size by Region (2025-2030) & (US$ Million)

Table 47. Latin America Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024) & (US$ Million)

Table 49. Latin America Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030) & (US$ Million)

Table 50. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 51. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2019-2024) & (US$ Million)

Table 52. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2025-2030) & (US$ Million)

Table 53. GlaxoSmithKline Company Detail

Table 54. GlaxoSmithKline Business Overview

Table 55. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product

Table 56. GlaxoSmithKline Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)

Table 57. GlaxoSmithKline Recent Development

Table 58. Pfizer Company Detail

Table 59. Pfizer Business Overview

Table 60. Pfizer Amino Acid Metabolism Disorder Drug Product

Table 61. Pfizer Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)

Table 62. Pfizer Recent Development

Table 63. AMINO Company Detail

Table 64. AMINO Business Overview

Table 65. AMINO Amino Acid Metabolism Disorder Drug Product

Table 66. AMINO Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)

Table 67. AMINO Recent Development

Table 68. Merck Company Detail

Table 69. Merck Business Overview

Table 70. Merck Amino Acid Metabolism Disorder Drug Product

Table 71. Merck Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)

Table 72. Merck Recent Development

Table 73. Recordati Company Detail

Table 74. Recordati Business Overview

Table 75. Recordati Amino Acid Metabolism Disorder Drug Product

Table 76. Recordati Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)

Table 77. Recordati Recent Development

Table 78. DSM Company Detail

Table 79. DSM Business Overview

Table 80. DSM Amino Acid Metabolism Disorder Drug Product

Table 81. DSM Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)

Table 82. DSM Recent Development

Table 83. Sanofi Company Detail

Table 84. Sanofi Business Overview

Table 85. Sanofi Amino Acid Metabolism Disorder Drug Product

Table 86. Sanofi Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)

Table 87. Sanofi Recent Development

Table 88. Kyowa Hakko Kirin Company Detail

Table 89. Kyowa Hakko Kirin Business Overview

Table 90. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Product

Table 91. Kyowa Hakko Kirin Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)

Table 92. Kyowa Hakko Kirin Recent Development

Table 93. BioMarin Company Detail

Table 94. BioMarin Business Overview

Table 95. BioMarin Amino Acid Metabolism Disorder Drug Product

Table 96. BioMarin Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)

Table 97. BioMarin Recent Development

Table 98. Swedish Orphan Biovitrum Company Detail

Table 99. Swedish Orphan Biovitrum Business Overview

Table 100. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product

Table 101. Swedish Orphan Biovitrum Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)

Table 102. Swedish Orphan Biovitrum Recent Development

Table 103. Shine Star (Hubei) Biological Engineering Company Detail

Table 104. Shine Star (Hubei) Biological Engineering Business Overview

Table 105. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product

Table 106. Shine Star (Hubei) Biological Engineering Revenue in Amino Acid Metabolism Disorder Drug Business (2019-2024) & (US$ Million)

Table 107. Shine Star (Hubei) Biological Engineering Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Amino Acid Metabolism Disorder Drug Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Amino Acid Metabolism Disorder Drug Market Share by Type: 2023 VS 2030

Figure 3. Arginine Features

Figure 4. Folic Acid Features

Figure 5. Vitamin B6 & B12 Features

Figure 6. Thiamine Features

Figure 7. Vitamin D Features

Figure 8. Betaine Features

Figure 9. Carglumic Acid Features

Figure 10. Sapropterin Dihydrochloride Features

Figure 11. Others Features

Figure 12. Global Amino Acid Metabolism Disorder Drug Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 13. Global Amino Acid Metabolism Disorder Drug Market Share by Application: 2023 VS 2030

Figure 14. Phenylketonuria Case Studies

Figure 15. Maple Syrup Urine Disease Case Studies

Figure 16. Argininosuccinic Acidemia Case Studies

Figure 17. Citrullinemia Case Studies

Figure 18. Homocystinuria Case Studies

Figure 19. Amino Acid Metabolism Disorder Drug Report Years Considered

Figure 20. Global Amino Acid Metabolism Disorder Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 21. Global Amino Acid Metabolism Disorder Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 22. Global Amino Acid Metabolism Disorder Drug Market Share by Region: 2023 VS 2030

Figure 23. Global Amino Acid Metabolism Disorder Drug Market Share by Players in 2023

Figure 24. Global Top Amino Acid Metabolism Disorder Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amino Acid Metabolism Disorder Drug as of 2023)

Figure 25. The Top 10 and 5 Players Market Share by Amino Acid Metabolism Disorder Drug Revenue in 2023

Figure 26. North America Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. North America Amino Acid Metabolism Disorder Drug Market Share by Country (2019-2030)

Figure 28. United States Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Canada Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Europe Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Europe Amino Acid Metabolism Disorder Drug Market Share by Country (2019-2030)

Figure 32. Germany Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. France Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. U.K. Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Italy Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Russia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Nordic Countries Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Asia-Pacific Amino Acid Metabolism Disorder Drug Market Share by Region (2019-2030)

Figure 40. China Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Japan Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Latin America Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Latin America Amino Acid Metabolism Disorder Drug Market Share by Country (2019-2030)

Figure 48. Mexico Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Brazil Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Country (2019-2030)

Figure 52. Turkey Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Amino Acid Metabolism Disorder Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. GlaxoSmithKline Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)

Figure 55. Pfizer Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)

Figure 56. AMINO Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)

Figure 57. Merck Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)

Figure 58. Recordati Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)

Figure 59. DSM Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)

Figure 60. Sanofi Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)

Figure 61. Kyowa Hakko Kirin Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)

Figure 62. BioMarin Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)

Figure 63. Swedish Orphan Biovitrum Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)

Figure 64. Shine Star (Hubei) Biological Engineering Revenue Growth Rate in Amino Acid Metabolism Disorder Drug Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Endoparasiticide Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36H8345

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Herpes Zoster Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34R905

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global SGLT2 Inhibitor Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2R9930

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Seasonal Affective Disorder Therapeutics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34L14446

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions